Apply to participate in Zynerba Fragile X Syndrome clinical trial in UK

Learn more about a clinical trial evaluating an investigational treatment to see if it helps behavioural issues related to Fragile X syndrome.

Qualified participants are:

  • Between 3 and 22 years of age
  • Diagnosed via genetic testing, with Fragile X syndrome
  • In generally good health

Apply to Participate